Steven Theriault

Steven Theriault

Company: Cytophage

Job title: Chief Executive Officer

Seminars:

Exploring Personalized vs Off-the-shelf Phage Therapies as Most Effective Therapies to Achieve Market Approval 1:30 pm

Utilizing personalized phage therapies that are tailored for specific disease indications How to choose an individualized or off-the-shelf phage therapy based on disease indication Developing a broad range phage cocktail as a rapid response to infection New Company!Read more

day: Conference Day Two

Fireside Chat: How Can Bacteriophage Therapies be Sustainable in the Market? 9:30 am

What indications should be prioritized to bring the first phage therapies to market How to ensure companies will sell bacteriophage therapy after receiving approval Understanding that route for smaller businesses who are working in the bacteriophage space Read more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.